9-methoxycamptothecin from Nothapodytes foetida induces apoptosis in murine sarcoma S180 cells

Na Liao1, Peng Zhang, Mingzhang Ao

  • 1Institute of Resource Biology and Biotechnology, Department of Biotechnology, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China.

Insights

9-Methoxycamptothecin (MCPT) induces apoptosis in murine sarcoma S180 cells. This study reveals that the mitochondria pathway is involved in MCPT

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Cancer Research

Background:

  • 9-Methoxycamptothecin (MCPT) exhibits antitumour properties via topoisomerase inhibition.
  • The specific mechanism of cell death induced by MCPT in tumour cells remained unclear.
  • Understanding MCPT's cellular effects is crucial for its therapeutic development.

Purpose of the Study:

  • To investigate the type of cell death induced by 9-Methoxycamptothecin (MCPT) in tumour cells.
  • To elucidate the molecular pathways involved in MCPT-mediated apoptosis.
  • To determine the efficacy of MCPT compared to camptothecin.

Main Methods:

  • Isolation and identification of MCPT and camptothecin from Nothapodytes foetida using NMR spectroscopy.
  • Antitumour activity assessment using the MTT assay and Annexin V-FITC/propidium iodide double staining.
  • Analysis of apoptosis-related gene expression (Bax and Bcl-2) via real-time PCR.

Main Results:

  • MCPT demonstrated significant antitumour activity with an IC50 value of (0.385 +/- 0.08) microM.
  • MCPT treatment dose-dependently increased apoptosis rates in S180 cells.
  • The Bax/Bcl-2 ratio increased significantly, indicating activation of the mitochondrial apoptosis pathway.

Conclusions:

  • 9-Methoxycamptothecin (MCPT) induces apoptosis in murine sarcoma S180 cells.
  • The mitochondrial pathway plays a key role in MCPT-induced apoptosis.
  • MCPT holds potential as an anticancer agent, warranting further investigation.

Related Concept Videos